Abstract
Patients undergoing hematopoietic stem cell typically require significant transfusion support. Blood product selection needs to consider the ABO and RhD types of both the donor and the recipient, as well as the appropriate product modifications needed to mitigate transfusion adverse events. Other considerations include optimal transfusion triggers, platelet refractoriness, and granulocyte transfusions. Close coordination between the transfusion and transplant services is necessary for optimal outcomes.
Original language | English |
---|---|
Title of host publication | Transfusion Medicine and Hemostasis |
Subtitle of host publication | Clinical and Laboratory Aspects |
Publisher | Elsevier |
Pages | 283-285 |
Number of pages | 3 |
ISBN (Electronic) | 9780323960144 |
ISBN (Print) | 9780323960151 |
DOIs | |
State | Published - 1 Jan 2024 |
Keywords
- ABO compatible
- HSC transplantation
- Major mismatch
- Minor mismatch
- RhD status
- Solid organ transplantation
- Transfusion support